Gilead Sciences (GILD) Dividend Coverage Ratio (2009 - 2026)
Gilead Sciences' (GILD) quarterly Dividend Coverage Ratio came in at 10.18 in Q2 2026, down 617.59% on a YoY basis from 1.97 in Q2 2025, and down 623.88% quarter-over-quarter from 1.94 in Q1 2026.
Analysis
Gilead Sciences (GILD) Dividend Coverage Ratio (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has reported Dividend Coverage Ratio for 13 consecutive years, with 10.18 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Dividend Coverage Ratio fell 617.59% year-over-year to 10.18; the trailing twelve-month figure through Jun 2026 stood at 0.71 (down 144.71% YoY), and the FY2025 full-year result was 2.13, up 1638.89% from the prior year.
- Dividend Coverage Ratio eased to 10.18 in Q2 2026 per GILD's latest filing, from 1.94 in the prior quarter.
- Across five years, Dividend Coverage Ratio topped out at 3.07 in Q3 2025 and bottomed at 10.18 in Q2 2026.
- Historically, Dividend Coverage Ratio has averaged 0.67 across 5 years, with a median of 1.57 in 2023.
- The sharpest annual moves came in 2023 and 2026: Dividend Coverage Ratio surged 7896.9% in 2023, then tumbled 617.59% in 2026.
- Over 5 years, Dividend Coverage Ratio stood at 1.76 in 2022, then dropped by 15.12% to 1.49 in 2023, then rose by 22.61% to 1.83 in 2024, then soared by 38.87% to 2.54 in 2025, then sank by 500.29% to 10.18 in 2026.
- According to Business Quant data, Dividend Coverage Ratio over the past three periods registered 10.18, 1.94, and 2.54 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 210.84 Bn | 196.85 Bn | 7.24 Bn | 1.74 |
| 2 | Gilead Sciences | 181.37 Bn | 178.19 Bn | 6.22 Bn | -10.18 |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.46 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.71 Bn | 74.72 Bn | 3.93 Bn | 13.40 |
| 5 | Argenx Se | 61.63 Bn | 56.45 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.66 Bn | 49.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.83 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.28 Bn | 29.99 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.30 Bn | 30.30 Bn | 1.16 Mn | - |
| 10 | Insmed | 28.23 Bn | 27.07 Bn | 358.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.18 |
| Mar 31, 2026 | 1.94 |
| Dec 31, 2025 | 2.54 |
| Sep 30, 2025 | 3.07 |
| Jun 30, 2025 | 1.97 |
| Mar 31, 2025 | 1.30 |
| Dec 31, 2024 | 1.83 |
| Sep 30, 2024 | 1.28 |
| Jun 30, 2024 | 1.65 |
| Mar 31, 2024 | -4.21 |
| Dec 31, 2023 | 1.49 |
| Sep 30, 2023 | 2.28 |
| Jun 30, 2023 | 1.09 |
| Mar 31, 2023 | 1.02 |
| Dec 31, 2022 | 1.76 |
| Sep 30, 2022 | 1.91 |
| Jun 30, 2022 | 1.22 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.42 |
| Sep 30, 2021 | 2.86 |